Simple Summary Adoption of single-fraction stereotactic body radiation therapy for lung
tumors has been limited among different institutions even during the coronavirus disease …

Purpose Owing to the coronavirus disease 2019 (COVID-19) pandemic, radiation oncology
departments have adopted various strategies to deliver radiation therapy safely and …

This overview summarises the current evidence on efficacy and safety of single-fraction
stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung …

Simple Summary The optimal way to treat central (CLT) and ultracentral (UCLT) lung tumors
with curative radiation is unclear. We evaluated 83 patients with CLT and UCLT who …

Background The role of neutrophil–lymphocyte ratio (NLR) as a predictor for survival in
single fraction SBRT-treated non-small cell lung cancer (NSCLC) patients remains unclear …

Stereotactic ablative radiotherapy (SABR) is a well-established treatment for patients with
medically inoperable early-stage non-small cell lung cancer (NSCLC) and pulmonary …

Abstract Stereotactic Body Radiation Therapy (SBRT) is a standard of care for many
localizations but the question of the optimal fractionation remains a matter of concern. If …

Purpose The objective of this study was to evaluate the incidence of brachial plexus injury
(BPI) after single-fraction stereotactic body radiation therapy (SBRT) to apical lung tumors …

Background To compare the clinical outcomes of patients with early-stage non–small-cell
lung cancer (NSCLC) who had undergone either single-fraction (SF) or three-fraction (TF) …

Background The purpose of the study was to evaluate the efficacy and safety of stereotactic
body radiotherapy (SBRT) for centrally located, primary non–small-cell lung cancer …